Phase III, randomized, double-blind, placebo-controlled clinical study: a study on the safety and clinical efficacy of AZVUDINE in moderate COVID-19 patients

BACKGROUND: In 2019, a highly pathogenic coronavirus named severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) surfaced and resulted in the outbreak of coronavirus disease 2019 (COVID-19). With the aim of finding effective drugs to fight against the disease, several trials have been conduct...

Descripción completa

Detalles Bibliográficos
Autores principales: de Souza, Sávio Bastos, Cabral, Paula Gebe Abreu, da Silva, Renato Martins, Arruda, Raul Ferraz, Cabral, Sheila Passos de Figueiredo, de Assis, Arícia Leone Evangelista Monteiro, Viana Junior, Antônio Brazil, Degrave, Wim Maurits Sylvain, Moreira, Aline dos Santos, Silva, Cléber Glória, Chang, Junbiao, Lei, Pingsheng
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2023
Materias:
Medicine
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10620601/
https://www.ncbi.nlm.nih.gov/pubmed/37928473
http://dx.doi.org/10.3389/fmed.2023.1215916

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10620601/
https://www.ncbi.nlm.nih.gov/pubmed/37928473
http://dx.doi.org/10.3389/fmed.2023.1215916

Ejemplares similares